Matthew Plack
About Matthew Plack
Matthew Plack serves as the Vice President of Enterprise Solution Sales at Apixio, where he has worked since 2021. He has extensive experience in sales and business development within the healthcare sector, having held various leadership roles at companies such as Cotiviti, HighRoads, and Siemens Medical Solutions.
Current Role at Apixio
Matthew Plack currently serves as Vice President of Enterprise Solution Sales at Apixio. He has held this position since 2021, contributing to the company's strategic sales initiatives and enterprise solutions. His role involves overseeing sales operations and driving business growth through innovative solutions tailored to the healthcare industry.
Previous Experience at Apixio
Matthew Plack has an extensive history with Apixio, having worked in various leadership roles. He served as Vice President of Business Development from 2016 to 2018 and later as Vice President of Major Accounts from 2019 to 2020. His tenure at Apixio has been marked by a focus on business development and managing key accounts.
Professional Background
Matthew Plack has held several significant positions in the healthcare and technology sectors. Before joining Apixio, he was Vice President of Client Engagement Leader at Cotiviti from 2015 to 2016. His earlier roles include positions at HighRoads, HealthMarketScience, and Siemens Medical Solutions Health Systems, where he developed expertise in sales, marketing, and strategic alliances.
Education and Expertise
Matthew Plack studied at Penn State University, where he earned a Master of Public Administration (MPA) with a concentration in Healthcare. His educational background supports his extensive experience in the healthcare industry, particularly in sales and client engagement.
Achievements in Revenue Generation
Throughout his career, Matthew Plack has demonstrated a strong ability in customer acquisition and retention. He has been instrumental in generating $9.4 million in annual recurring revenue. Notably, he successfully negotiated a pilot project for the largest Medicare Advantage plan, resulting in a three-year partnership that delivered over $7 million in revenue.